PRN prescribing in psychiatric inpatients - Potential for pharmacokinetic drug interactions (Journal of Psychopharmacology 21, 2, DOI: 10.1177/0269881107067242);PRN prescribing in psychiatric inpatients - Potential for pharmacokinetic drug interactions

Journal of Psychopharmacology

Volumn 21, Issue 2, 2007, Pages 153-160

  Davies, Simon J C ^a   Lennard, Martin S ^b   Ghahramani, Parviz ^b   Pratt, Peter ^c   Robertson, Andrea ^a   Potokar, John ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c SHEFFIELD HEALTH AND SOCIAL CARE NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Clinical psychiatry; Cytochrome P450; Drug interactions; Pharmacokinetics; PRN prescribing

Indexed keywords

ALPRAZOLAM; AMIODARONE; AMITRIPTYLINE; CARBAMAZEPINE; CHLORPROMAZINE; CITALOPRAM; CLOMIPRAMINE; COCODAMOL; CYTOCHROME P450 2D6; CYTOCHROME P450 3A4; DEXTROPROPOXYPHENE PLUS PARACETAMOL; DIAZEPAM; DIHYDROCODEINE; FLUOXETINE; HALOPERIDOL; IMIPRAMINE; METOPROLOL; NEFAZODONE; OMEPRAZOLE; ORAL CONTRACEPTIVE AGENT; PAROXETINE; PROPRANOLOL DERIVATIVE; RISPERIDONE; SERTRALINE; TEMAZEPAM; THIORIDAZINE; TRAZODONE; UNINDEXED DRUG; ZOPICLONE; ZUCLOPENTHIXOL;

AGED; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD; MENTAL DISEASE; MENTAL PATIENT; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; PSYCHOSIS; WARD;

EID: 33847097461     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881108096187     Document Type: Erratum

References (22)

1. Ayd F J (1985) Problems with orders for medication as needed. American Journal of Psychiatry 142: 939 - 942
2. Bowden M F (1999) Audit: prescription of 'as required' (p.r.n.) medication in an inpatient setting. Psychiatric Bulletin 23: 413 - 416
3. Craven J, Voore P, Voineskos G (1987) PRN medication in psychiatric inpatients. Canadian Journal of Psychiatry 32: 199 - 203
4. Crewe H K, Lennard M S, Tucker G T, Woods F R, Haddock R E (1992) The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes. British Journal of Clinical Pharmacology 34: 262 - 265
5. Davies S J C, Eayrs S, Pratt P, Lennard M S (2004) Potential for drug interactions involving cytochromes P450 2D6 and 3A4 on general adult and functional elderly psychiatric wards. British Journal of Clinical Pharmacology 57: 464 - 472
6. Geffen J, Sorensen L, Stokes J, Cameron A, Roberts M S, Geffen L (2002) Pro re nata medication for psychoses: an audit of practice in two metropolitan hospitals. Australian and New Zealand Journal of Psychiatry 36: 649 - 656
7. Lennard M S (1990) Genetic polymorphism of sparteine/debrisoquine oxidation: a reappraisal. Pharmacology and Toxicology 67: 273 - 283
8. McAllister-Williams R H, Ferrier I N (2002) Rapid tranquillisation: time for a reappraisal of options for parenteral therapy. British Journal of Psychiatry 180: 485 - 489
9. McLaren S, Browne F, Taylor P (1990) A study of psychotropic medication given 'as required' in a secure regional unit. British Journal of Psychiatry 156: 732 - 735
10. Medicines Control Agency/Committee on Safety of Medicines (2001) QT interval prolongation with antipsychotics. Current Problems in Pharmacovigilance 27: 4-4
11. Milton J, Lawton J, Smith M, Buckley A (1998) Hidden high-dose antipsychotic prescribing: effect of p.r.n doses. Psychiatric Bulletin 22: 675 - 677
12. Mitchell P B (1997) Drug interactions of clinical significance with selective serotonin reuptake inhibitors. Drug Safety 17: 390 - 406
13. Pickersgill T (2001) The European working time directive for doctors in training. British Medical Journal 323: 1266-1266
14. Pollock B G (1994) Recent developments in drug metabolism of relevance to psychiatrists. Harvard Review of Psychiatry 2: 204 - 213
15. Reilly J G, Ayis S A, Ferrier I N, Jones S J, Thomas S H L (2000) QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet 355: 1048 - 1052
16. Royal College of Psychiatrists Psychopharmacology Sub-Group (1997) The association between antipsychotic drugs and sudden death. Council Report CR57, Royal College of Psychiatrists, London
17. Stockley I H (2002) Drug Interactions. The Pharmaceutical Press, London
18. Taylor D, Paton C, Kerwin R (2005) Maudsley Prescribing Guidelines 2003, 8th edn. Taylor & Francis, London
19. Tiseo P J, Perdomo C A, Friedhoff L T (1998) Concurrent administration of donepezil HCl and ketoconazole: assessment of pharmacokinetic changes following single and multiple doses. British Journal of Clinical Pharmacology 46 (suppl. 1). 30 - 34
20. Usher K, Luck L (2004) Psychotropic PRN: a model for best practice management of acute psychotic behavioural disturbance in inpatient psychiatric settings. International Journal of Mental Health Nursing 13: 18 - 21
21. Vandel S, Bertschy G, Baumann P, Bouquet S, Bonin B, Francois T, Sechter D, Bizouard P (1995) Fluvoxamine and fluoxetine: interaction studies with amitriptyline, clomipramine and neuroleptics in phenotyped patients. Pharmacological Research 31: 347 - 353
22. Whicher E, Morrison M, Douglas-Hall P (2004) 'As required' medication regimens for seriously mentally ill people in hospital (Cochrane Review). In: The Cochrane Library, Issue 2. John Wiley, Chichester